Skip to content
WorkingMomRx
Menu

We may earn a commission from provider links, at no added cost to you. Compensation never changes scores; some lists place partners first. Read our affiliate disclosure.

Head-to-head

Zealthy vs Ivim Health

Zealthy and Ivim Health both offer GLP-1 telehealth, but they make different trade-offs on speed to first dose, flat pricing, access and molecule choice. Here they are side-by-side on the Rx-Readiness Score — our readiness rubric.

Zealthy

Ranked #311 · Grade C

Best for: Nothing, while the federal case is open. It stays on the board for transparency, not as a suggestion.

Visit Zealthy
vs

Ivim Health

Higher score

Ranked #279 · Grade C

Best for: Someone who wants regular provider contact and can commit to a defined program after confirming the full cost.

Visit Ivim Health

The verdict

Higher Rx-Readiness Score: Ivim Health

Ivim Health edges out Zealthy on the Rx-Readiness Score, 45 to 39 (C vs C). Someone who wants regular provider contact and can commit to a defined program after confirming the full cost.

Zealthy is still a genuine option — fDA warning letter #716501 (September 2025), which names getzealthy.com, and in April 2026 the FTC and DOJ moved to seize the company and freeze its assets. Read both before anything else here. On the money: read live on 26 August 2026, self-pay semaglutide is advertised at "as little as $151/month" and brand Ozempic, Wegovy, Zepbound and Mounjaro at "as low as $25/month" with insurance — two figures that are not comparable, because the second is a copay that depends on your plan and the same paragraph quotes $1,349 without coverage. No tirzepatide price is published anywhere. A "$96 off your first month" banner runs site-wide and its own policy confirms the rate reverts to full afterward. Cancellation is self-serve and documented step by step, but there is no prorated refund, medication is final once shipped, and the policy warns members may be required to sign up for multiple months to keep supply continuous. Four months after the federal petition it is still trading normally under the same entity, FitRX, LLC dba Zealthy, at the same New York address the FDA letter used. Weigh the six readiness factors below against your own priorities.

Side-by-side on the six factors

Both providers scored on the same readiness rubric — the higher side on each factor is marked. See the methodology.

Zealthy Ivim Health
Time to first dose6260
Zealthy
Ivim
Flat, predictable pricing2540
Zealthy
Ivim
No-video (async) intake3030
Zealthy
Ivim
Nationwide access3025
Zealthy
Ivim
Both molecules on one plan6292
Zealthy
Ivim
Easy off-ramp2225
Zealthy
Ivim

Price, access & features

DetailZealthyIvim Health
Rx-Readiness Score39/100 · C45/100 · C
Overall rank#311#279
SemaglutideFrom $151/mo self-payFrom $75/mo medication only; selected program plus membership
TirzepatideNot priced on the public siteFrom $133/mo medication only; selected program plus membership
CoverageNot published on the public siteConfirm state eligibility before payment
Brand-name accessYesYes
Oral / sublingualInjection onlyYes

Zealthy

Ranked #311 · Grade C

What we like

  • Both self-pay and insured figures are published on the public page before any form
  • Brand Ozempic, Wegovy, Zepbound and Mounjaro sit on the menu alongside compounded semaglutide, and it works with major insurers
  • Same-day appointments are advertised, and the published intake takes about five minutes before the visit

The caveats

  • April 2026: the FTC and DOJ asked a federal court to place Zealthy in receivership and freeze its assets, alleging deceptive disclosures, obstructive cancellation and review manipulation
  • The same complaint alleges misuse of clinicians' NPI numbers to issue prescriptions without their knowledge or consent — the government's words are that Zealthy is "actively deceiving telehealth patients, endangering their safety, and raiding their bank accounts". These are allegations, not findings; the case is ongoing
  • Separately, and earlier: FDA warning letter #716501, dated September 9, 2025, to FitRX, LLC dba Zealthy, over the unlawful sale of unapproved and misbranded compounded semaglutide — the letter names getzealthy.com, and its address, 30 Irving Pl in New York, is the one the live site prints today

Ivim Health

Ranked #279 · Grade C

What we like

  • Separate membership fee is published before signup
  • Branded and compounded treatment options are listed
  • GLP-1 ID describes video or chat visits and weekly check-ins

The caveats

  • The medication headline excludes $74.99 monthly membership
  • Selected-term membership fees remain payable after a mid-term stop
  • Microdosing prices do not establish standard weight-loss maintenance pricing

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes a Rx-Readiness Score. Pricing, states and verification reflect each provider's public disclosures at last review; the Rx-Readiness Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

More head-to-heads

Keep comparing Zealthy and Ivim Health against other providers on our shortlist.

Or browse the full comparison hub.